Deltex Medical Group plc
DEMG.L · LSE
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.04 | 0.00 | -0.64 | -0.02 |
| FCF Yield | -91.37% | -19.69% | -11.30% | -3.24% |
| EV / EBITDA | -2.92 | -9.68 | -13.19 | -15.04 |
| Quality | ||||
| ROIC | -19.24% | -21.79% | -27.32% | -23.20% |
| Gross Margin | 63.34% | 70.39% | 65.65% | 64.51% |
| Cash Conversion Ratio | 0.95 | 0.53 | 0.30 | 0.09 |
| Growth | ||||
| Revenue 3-Year CAGR | -7.71% | 1.15% | -19.03% | -21.49% |
| Free Cash Flow Growth | -15.93% | -44.39% | -291.21% | -168.48% |
| Safety | ||||
| Net Debt / EBITDA | -1.21 | -1.98 | -2.13 | -1.16 |
| Interest Coverage | -4.57 | -5.27 | -6.71 | -6.05 |
| Efficiency | ||||
| Inventory Turnover | 0.91 | 0.90 | 0.97 | 0.95 |
| Cash Conversion Cycle | 340.82 | 240.93 | 321.81 | 409.84 |